Given the data and tweets, could you project whether the closing price of $amgn will grow or shrink at 2017-01-31? Please specify either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-01-17,0.2,0.9,-0.8,-0.8,-0.8,1.0,0.4,-1.3,-2.2,-2.7,-3.5
2017-01-18,-0.1,0.1,-0.8,0.6,0.6,-0.0,0.1,-1.6,-2.6,-3.0,-3.9
2017-01-19,0.9,1.2,-0.4,-1.3,-1.3,0.9,1.4,-0.1,-1.1,-1.6,-2.4
2017-01-20,0.0,0.4,-0.5,0.6,0.6,0.2,1.0,-0.3,-1.5,-1.9,-2.8
2017-01-23,1.0,1.2,-0.2,-1.3,-1.3,1.1,2.0,1.1,0.0,-0.6,-1.3
2017-01-24,0.6,0.8,-1.0,-0.6,-0.6,1.3,2.1,2.0,0.8,0.0,-0.5
2017-01-25,-1.0,0.5,-1.5,1.5,1.5,-0.4,0.3,0.6,-0.5,-1.3,-1.7
2017-01-26,1.3,1.8,-0.1,-0.7,-0.7,0.2,0.8,1.4,0.4,-0.5,-0.8
2017-01-27,-2.5,0.2,-2.8,2.7,2.7,-2.2,-1.8,-1.1,-2.0,-2.9,-3.3
2017-01-30,1.7,1.8,-0.4,-1.7,-1.7,-0.2,-0.1,0.5,-0.0,-0.9,-1.4

2017-01-17: excalibur management corp continues to hold position in amgen inc. $amgn |$amgn max pain is 155.00 for maturity 01/20/2017. prev close = 156.12.   |excalibur management corp continues to hold position
2017-01-18: aspen investment management inc boosts stake in amgen inc. $amgn |$fgen must look roxadustat slide deck-not seen before-but clearly shows advantages over esa $amgn clear benefits wh¡­ |$amgn sum put v
2017-01-19: rt AT_USER atlassian q2 revenue tops views, but q3 earnings guidance misses:  $team $amgn $blk $bid|atlassian q2 revenue tops views, but q3 earnings guidance misses:  $team $amgn $blk $bid |atlassian 
2017-01-20: amgen inc. $amgn position held by american assets investment management llc |amgen inc. $amgn position held by american assets investment management llc |rt AT_USER cimzia beats enbrel in head-to-head
2017-01-21: $amgn max pain is 152.50 for maturity 01/27/2017. prev close = 154.67.   |rt AT_USER 13 stocks that could explode    $myl $rrc $evhc $fb $rl $crm $regn $pxd $amgn $nbl $amzn $eog $swn|rt AT_USER cowen
2017-01-22: $amgn high open interest range is 150.00 to 160.00 for option expiration 01/27/2017.  |rt AT_USER and as expected, $amgn raises enbrel price 8.4% 3 days after identical hike from $abbv, per raymond ja
2017-01-23: quotes AT_USER $acad $amgn $twtr $xbi |jefferies top cheap biotech and pharma stock picks for 2017 .  via AT_USER $abbv $amgn $gild $celg|rt AT_USER technical action by s&amp;p 500 stocks to 10:00: bu
2017-01-24: rt AT_USER interesting! lots of upside since then  $vrx $agn $iep $twtr $hlf $aapl $fb $amgn $jnj $myl $mrk $srpt $amzn $shak $hd $exe¡­|argent trust co raises stake in amgen inc. $amgn |palisades hud
2017-01-25: $amgn may go up 6% if the bull pattern is confirmed. chk confirmation [58%] @  buy level:154.1000.|5 things for #pharma #marketers to know: wed., jan. 25 $nvs $amgn $atln #pah $jnj #hhs #tomprice #aca
2017-01-26: $blph insiders bought a ton of shares at 12$ im getting mine at 65 cents ;)  $imnp $amrn $tgtx $acad $sny $juno $antm $amgn|fy2019 eps estimates for amgen inc. lowered by leerink swann $amgn |fy2019 e
2017-01-27: $amgn the bull pattern is confirmed &amp; a buy signal is issued @  buy level: 154.2125   target: 163.4652|#options #maxpain chart for $amgn. free stock station app  #itunes |$amgn #options oi chart. 
2017-01-28:  &lt; review of this fantastic traders teaching service!! try it for free! $lly $dgx $mrk $nvs $amgn|rt AT_USER $amgn $adi video plans. in this video i explain the facts   confirmation is key    |$amg
2017-01-29: rt AT_USER notable earnings jan30 - feb3: tue $aapl $amd $pfe $s $xom $ups $ea; wed $fb $jci; thu $amzn $feye $cmg $nok $v $gpro $¡­|rt AT_USER notable earnings jan30 - feb3: tue $aapl $amd $pfe $s $x
2017-01-30: biogen: an attractive long in a beaten-down industry  $amgn $bivvv $celg $ibb $biib|#amgen announces webcast of 2016 fourth quarter and full year financial results  $amgn|biogen: an attractive long in
Answer:
Rise